The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Phase II study of savolitinib in patients (pts) with pulmonary sarcomatoid carcinoma (PSC) and other types of non-small cell lung cancer (NSCLC) harboring MET exon 14 skipping mutations (METex14+).
 
Shun Lu
Consulting or Advisory Role - AstraZeneca; Boehringer Ingelheim; Hutchison MediPharma; Roche; Simcere
Speakers' Bureau - AstraZeneca; Hansoh; Roche
Research Funding - AstraZeneca; Bristol-Myers Squibb; HenRui; Hutchison MediPharma; Roche
 
Jian Fang
No Relationships to Disclose
 
Xingya Li
No Relationships to Disclose
 
Lejie Cao
No Relationships to Disclose
 
Jianying Zhou
No Relationships to Disclose
 
Qisen Guo
No Relationships to Disclose
 
Zongan Liang
No Relationships to Disclose
 
Ying Cheng
No Relationships to Disclose
 
Liyan Jiang
No Relationships to Disclose
 
Nong Yang
No Relationships to Disclose
 
Zhigang Han
No Relationships to Disclose
 
Jianhua Shi
No Relationships to Disclose
 
Yuan Chen
No Relationships to Disclose
 
Hua Xu
No Relationships to Disclose
 
Helong Zhang
No Relationships to Disclose
 
Di Zhang
Employment - Hutchison MediPharma
 
Jing Li
Employment - Hutchison MediPharma
 
Linfang Wang
Employment - Hutchison MediPharma
 
Yongxin Ren
Employment - Hutchison MediPharma
 
Weiguo Su
Employment - Hutchison MediPharma
Stock and Other Ownership Interests - Hutchison MediPharma